-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 12, Baiyunshan issued an announcement stating that the branch Guangzhou Baiyunshan Pharmaceutical Group Co.
The amoxicillin capsule of Baiyunshan Pharmaceutical General Factory was officially launched in China in August 2006, and the consistency evaluation application was submitted to the National Medical Products Administration on November 4, 2018, and it was accepted on November 12, 2018
Amoxicillin is a semi-synthetic penicillin antibiotic, used for the following infections caused by sensitive bacteria (strains that do not produce β-lactamase): Otitis media and sinusitis caused by Streptococcus hemolyticus, Streptococcus pneumoniae, Staphylococcus or Haemophilus influenzae , Pharyngitis, tonsillitis and other upper respiratory tract infections; genitourinary tract infections caused by Escherichia coli, Proteus mirabilis or Enterococcus faecalis; skin and soft tissue infections caused by Streptococcus hemolyticus, Staphylococcus or Escherichia coli; hemolytic chain aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Staphylococcus aureus caused by acute bronchitis, pneumonia and other respiratory tract infections; acute uncomplicated gonorrhea and so on
Currently in China listed amoxicillin capsule manufacturers also include Zhuhai United Laboratories Co.
According to data from Minai.
As of the date of this announcement, Baiyunshan Pharmaceutical General Factory has invested approximately RMB 7.